Australia's most trusted
source of pharma news
Friday, 27 December 2024
Posted 10 December 2024 AM
The PBAC has provided a broad brushstroke on what occurred during a recent stakeholder meeting on oral contraceptives (OCPs), attended by Bayer, Besins Healthcare, Mayne Pharma, Organon, and Theramex.
Held in October at the request of Health Minister, Mark Butler, the meeting sought to increase understanding of what evidence is available that may demonstrate that newer OCPs offer additional benefits compared to older generation OCPs.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.